Aroa Historical Income Statement

ARX Stock

0.80 0.05 6.67%

Historical analysis of Aroa Biosurgery income statement accounts such as Selling General Administrative of 652.9 K, Total Revenue of 76.5 M or Cost Of Revenue of 11.2 M can show how well Aroa Biosurgery performed in making a profits. Evaluating Aroa Biosurgery income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Aroa Biosurgery's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Aroa Biosurgery latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aroa Biosurgery is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aroa Biosurgery. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Aroa Income Statement Analysis

Aroa Biosurgery Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Aroa Biosurgery shareholders. The income statement also shows Aroa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Aroa Biosurgery Income Statement Chart

At this time, Aroa Biosurgery's Net Interest Income is comparatively stable compared to the past year.

Interest Expense Selling General Administrative Cost Of Revenue Income Before Tax Total Operating Expenses Depreciation And Amortization

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Cost Of Revenue

Cost of Revenue is found on Aroa Biosurgery income statement and represents the costs associated with goods and services Aroa Biosurgery provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Aroa Biosurgery income statement and is an important metric when analyzing Aroa Biosurgery profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most accounts from Aroa Biosurgery's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Aroa Biosurgery current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aroa Biosurgery. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Aroa Biosurgery's Net Interest Income is comparatively stable compared to the past year.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	3.5M	4.0M	4.6M	2.9M
Interest Income	2.7M	1.7M	1.9M	1.1M

Depreciation And Amortization Interest Income

Aroa Biosurgery income statement Correlations

	Selling General Administrative	Total Revenue	Cost Of Revenue	Income Tax Expense	Income Before Tax	Net Income	Gross Profit	Operating Income	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Interest Income	Depreciation And Amortization	Other Operating Expenses	Research Development	Ebitda	Net Interest Income	Selling And Marketing Expenses	Reconciled Depreciation
Selling General Administrative		0.3	0.43	-0.11	-0.15	-0.13	0.26	-0.05	-0.2	-0.01	0.39	0.02	0.01	0.48	0.42	0.38	0.53	0.19	0.43	0.09	0.0
Total Revenue	0.3		0.92	0.01	-0.51	-0.51	1.0	-0.52	-0.41	-0.55	0.99	0.17	0.23	0.83	0.92	0.92	0.92	-0.29	0.91	0.89	0.87
Cost Of Revenue	0.43	0.92		-0.24	-0.59	-0.54	0.89	-0.54	-0.54	-0.55	0.91	-0.07	0.01	0.76	0.9	0.84	0.86	-0.28	0.76	0.72	0.69
Income Tax Expense	-0.11	0.01	-0.24		-0.01	-0.18	0.05	-0.22	0.06	-0.21	0.07	0.42	0.9	-0.2	-0.02	0.08	0.07	-0.29	0.15	0.15	0.14
Income Before Tax	-0.15	-0.51	-0.59	-0.01		0.98	-0.49	0.96	0.85	0.95	-0.57	0.51	-0.24	-0.17	-0.67	-0.53	-0.53	0.88	-0.26	-0.37	-0.36
Net Income	-0.13	-0.51	-0.54	-0.18	0.98		-0.49	0.97	0.82	0.97	-0.57	0.41	-0.42	-0.13	-0.66	-0.54	-0.54	0.91	-0.29	-0.39	-0.38
Gross Profit	0.26	1.0	0.89	0.05	-0.49	-0.49		-0.51	-0.38	-0.54	0.98	0.22	0.26	0.83	0.9	0.92	0.91	-0.29	0.93	0.91	0.89
Operating Income	-0.05	-0.52	-0.54	-0.22	0.96	0.97	-0.51		0.74	1.0	-0.58	0.34	-0.39	-0.14	-0.64	-0.55	-0.54	0.95	-0.31	-0.43	-0.43
Net Income From Continuing Ops	-0.2	-0.41	-0.54	0.06	0.85	0.82	-0.38	0.74		0.73	-0.44	0.74	-0.11	-0.14	-0.62	-0.4	-0.39	0.62	-0.11	-0.21	-0.21
Ebit	-0.01	-0.55	-0.55	-0.21	0.95	0.97	-0.54	1.0	0.73		-0.6	0.32	-0.39	-0.17	-0.66	-0.57	-0.54	0.95	-0.33	-0.47	-0.47
Total Operating Expenses	0.39	0.99	0.91	0.07	-0.57	-0.57	0.98	-0.58	-0.44	-0.6		0.17	0.3	0.81	0.93	0.94	0.95	-0.35	0.92	0.87	0.84
Total Other Income Expense Net	0.02	0.17	-0.07	0.42	0.51	0.41	0.22	0.34	0.74	0.32	0.17		0.4	0.3	-0.06	0.19	0.2	0.34	0.5	0.37	0.34
Tax Provision	0.01	0.23	0.01	0.9	-0.24	-0.42	0.26	-0.39	-0.11	-0.39	0.3	0.4		-0.05	0.21	0.29	0.29	-0.41	0.33	0.32	0.3
Interest Income	0.48	0.83	0.76	-0.2	-0.17	-0.13	0.83	-0.14	-0.14	-0.17	0.81	0.3	-0.05		0.79	0.85	0.85	0.11	0.88	0.81	0.78
Depreciation And Amortization	0.42	0.92	0.9	-0.02	-0.67	-0.66	0.9	-0.64	-0.62	-0.66	0.93	-0.06	0.21	0.79		0.96	0.95	-0.41	0.8	0.84	0.81
Other Operating Expenses	0.38	0.92	0.84	0.08	-0.53	-0.54	0.92	-0.55	-0.4	-0.57	0.94	0.19	0.29	0.85	0.96		0.98	-0.33	0.9	0.94	0.9
Research Development	0.53	0.92	0.86	0.07	-0.53	-0.54	0.91	-0.54	-0.39	-0.54	0.95	0.2	0.29	0.85	0.95	0.98		-0.29	0.92	0.87	0.82
Ebitda	0.19	-0.29	-0.28	-0.29	0.88	0.91	-0.29	0.95	0.62	0.95	-0.35	0.34	-0.41	0.11	-0.41	-0.33	-0.29		-0.09	-0.27	-0.29
Net Interest Income	0.43	0.91	0.76	0.15	-0.26	-0.29	0.93	-0.31	-0.11	-0.33	0.92	0.5	0.33	0.88	0.8	0.9	0.92	-0.09		0.88	0.83
Selling And Marketing Expenses	0.09	0.89	0.72	0.15	-0.37	-0.39	0.91	-0.43	-0.21	-0.47	0.87	0.37	0.32	0.81	0.84	0.94	0.87	-0.27	0.88		0.99
Reconciled Depreciation	0.0	0.87	0.69	0.14	-0.36	-0.38	0.89	-0.43	-0.21	-0.47	0.84	0.34	0.3	0.78	0.81	0.9	0.82	-0.29	0.83	0.99

Click cells to compare fundamentals

Aroa Biosurgery Account Relationship Matchups

Aroa Biosurgery income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	1.4M	697.1K	5.6K	1.2M	1.3M	1.4M
Selling General Administrative	20.0M	28.5M	47.7M	597.6K	687.2K	652.9K
Total Revenue	20.5M	36.9M	59.3M	63.4M	72.9M	76.5M
Cost Of Revenue	6.3M	8.7M	9.3M	9.3M	10.6M	11.2M
Income Tax Expense	98.2K	116.2K	11.2K	184.4K	165.9K	174.2K
Income Before Tax	(17.5M)	(7.7M)	(359.5K)	(9.6M)	(8.6M)	(8.2M)
Net Income Applicable To Common Shares	(6.0M)	(19.2M)	(8.4M)	(396K)	(356.4K)	(374.2K)
Net Income	(17.6M)	(7.8M)	(370.7K)	(9.7M)	(8.8M)	(8.3M)
Gross Profit	14.3M	28.2M	50.1M	54.1M	62.2M	65.3M
Operating Income	(16.2M)	(7.0M)	(353.8K)	(9.8M)	(8.8M)	(8.4M)
Ebit	(17.4M)	(6.7M)	(5.5K)	(11.4M)	(10.3M)	(9.7M)
Total Operating Expenses	28.7M	39.2M	58.2M	54.1M	62.2M	65.3M
Total Other Income Expense Net	(3.1M)	(697.1K)	2.6M	223.8K	201.4K	211.5K
Tax Provision	98.2K	116.2K	12K	184.4K	212.0K	222.6K
Interest Income	141.4K	374.6K	2.7M	1.7M	1.9M	1.1M
Depreciation And Amortization	2.9M	3.0M	3.5M	4.0M	4.6M	2.9M
Other Operating Expenses	35.0M	47.9M	67.4M	73.1M	84.1M	44.6M
Research Development	5.9M	7.8M	9.9M	8.5M	9.8M	6.8M
Ebitda	(14.6M)	(3.7M)	3.5M	(7.4M)	(6.6M)	(6.3M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aroa Stock Analysis

When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC